Abstract
Abstract
The distinction between myasthenia gravis and Lambert-Eaton myasthenic syndrome is based on clinical, neurophysiological and immunological features. We hereby report two cases with a clinical diagnosis of myasthenia gravis and neurophysiological features consistent with a pre-synaptic neuromuscular transmission defect. Both patients had increased anti-acetylcholine receptor antibody titres and showed a good response to cholinesterase inhibitors, along with a >100% facilitation of the compound muscle action potential on electrophysiological studies. We provide a review of English literature studies on co-existing features of myasthenia gravis and Lambert-Eaton myasthenic syndrome, and discuss diagnostic controversies.
Lingua originale | English |
---|---|
pagine (da-a) | 646-650 |
Numero di pagine | 5 |
Rivista | Neuromuscular Disorders |
Volume | 25 |
DOI | |
Stato di pubblicazione | Pubblicato - 2015 |
Keywords
- 3,4-diaminopyridine
- Cholinesterase inhibitors
- Lambert-Eaton myasthenic syndrome
- Myasthenia gravis